Details of the Drug Reposition

General Information of This Drug (ID: DMLIPY1)

Drug Name
Xmab 5871   DMLIPY1
Synonyms XmAb 5871 (TN)

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Systemic lupus erythematosus DISI1SZ7 4A40.0 Phase 2 [1]
IgG4 related disease DIS1U0UF 4A43.0 Phase 2 [1]
Autoimmune diabetes DISW6UF1 5A10 Phase 2 [2]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Phase 1/2 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035125)
3 ClinicalTrials.gov (NCT02867098) XmAb5871 Bioavailability Study